Table 4 Sexual health, overdose, and harm reduction among persons who recently used drugs in a County within the jurisdiction of a tribal Nation in the Southern plains (USA), April-May 2023
|  | Overall (N = 209)*; n (%) | Self-identify as American Indian (N = 112*); n (%) | White (N = 77); n (%) | p-value |
|---|---|---|---|---|
Sexual Health Behaviors | Â | Â | Â | Â |
 STI test within the past year | 78 (37.3) | 49 (43.8) | 25 (32.5) | 0.159 |
 HIV test within the past year | 82 (39.2) | 49 (43.8) | 24 (31.2) | 0.111 |
 HCV test within the past year | 85 (40.7) | 53 (47.3) | 24 (31.2) | 0.038 |
Overdose Experiences | Â | Â | Â | Â |
 Experienced overdose, ever | 71 (34.0) | 38 (33.9) | 28 (36.4) | 0.850 |
 Overdose in past 6 months | 40 (19.1) | 21 (18.8) | 19 (24.7) | 0.367 |
 Witnessed a nonfatal overdose, ever | 94 (45.0) | 52 (46.4) | 35 (45.5) | 1 |
 Witnessed a nonfatal overdose, past 6 months | 66 (31.6) | 38 (33.9) | 25 (32.5) | 0.958 |
 Witnessed a fatal overdose, ever | 52 (24.9) | 33 (29.5) | 16 (20.8) | 0.237 |
 Witnessed a fatal overdose, past 6 months | 31 (14.8) | 19 (17.0) | 11 (14.3) | 0.689 |
Harm Reduction | Â | Â | Â | Â |
 Heard of fentanyl test strips | 87 (41.6) | 53 (47.3) | 31 (40.3) | 0.417 |
 Acquired naloxone, past 6 months | 50 (23.9) | 26 (23.2) | 20 (26.0) | 0.793 |
 Administered naloxone, past 6 months | 42 (20.1) | 25 (22.3) | 13 (16.9) | 0.504 |
 Willing to distribute naloxone | 128 (61.2) | 69 (61.6) | 48 (62.3) | 1 |
 Willing to use a public health vending machine | 135 (64.6) | 68 (60.7) | 54 (70.1) | 0.240 |
 Willing to distribute take home HIV tests | 129 (61.7) | 65 (58.0) | 51 (66.2) | 0.325 |
 Willing to use a needle exchange | 113 (54.1) | 63 (56.3) | 43 (55.8) | 1 |